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Abstract
Background
The immediate postnatal period is the period of the fastest growth in the entire life span and
a critical period for lung development. Therefore, it is interesting to examine the association
between growth during this period and childhood respiratory disorders.
Methods
We examined the association of peak weight and height velocity to age 36 months with ma-
ternal report of current asthma at 36 months (n = 50,311), recurrent lower respiratory tract
infections (LRTIs) by 36 months (n = 47,905) and current asthma at 7 years (n = 24,827) in
the Norwegian Mother and Child Cohort Study. Peak weight and height velocity was calcu-
lated using the Reed1 model through multilevel mixed-effects linear regression. Multivari-
able log-binomial regression was used to calculate adjusted relative risks (adj.RR) and 95%
confidence intervals (CI). We also conducted a sibling pair analysis using conditional logis-
tic regression.
Results
Peak weight velocity was positively associated with current asthma at 36 months [adj.RR
1.22 (95%CI: 1.18, 1.26) per standard deviation (SD) increase], recurrent LRTIs by 36
months [adj.RR 1.14 (1.10, 1.19) per SD increase] and current asthma at 7 years [adj.RR
1.13 (95%CI: 1.07, 1.19) per SD increase]. Peak height velocity was not associated with
any of the respiratory disorders. The positive association of peak weight velocity and
asthma at 36 months remained in the sibling pair analysis.
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Conclusions
Higher peak weight velocity, achieved during the immediate postnatal period, increased the
risk of respiratory disorders. This might be explained by an influence on neonatal lung de-
velopment, shared genetic/epigenetic mechanisms and/or environmental factors.
INTRODUCTION
Asthma is the most common chronic disease during childhood [1]. Early childhood wheezing
symptoms are often linked to lower respiratory tract infections (LRTIs) [2]. Restricted intra-
uterine growth [3,4], small size at birth [5,6] and higher adiposity during childhood are posi-
tively associated with asthma [7–10]. Previous studies with anthropometric measurements
throughout childhood report positive [11–16], inverse [17] and null associations [18] between
weight increase and asthma. A recent meta-analysis further report a positive association of
absolute weight gain between birth and 12 months with asthma [19]. Most previous studies re-
port no association between length increase and asthma [11–14]. No previous study of postna-
tal growth and asthma has included an evaluation of LRTIs.
Neonatal lung function increases with birth weight and birth length [20]. Neonatal lung
function is also inversely associated with asthma development [21]. Plausible mechanisms un-
derlying an association between early childhood growth and respiratory disorders include
growth factors influencing lung development [22,23], shared genetic and epigenetic mecha-
nisms [24,25], in addition to common environmental influences such as for example infant
feeding [26,27].
In contrast to birth weight and childhood growth trajectories, less research exists on growth
during the immediate postnatal period and respiratory disorders. This immediate postnatal pe-
riod is the period of the fastest growth in the entire life span and a critical period for lung devel-
opment [22]. Only one study has previously evaluated peak height and weight velocity, usually
reached within the first month of life, in relation to asthma [13]. Peak height and weight veloci-
ty has been associated with fetal growth in a study from the Netherlands [28]. In the same
study, peak weight velocity was also positively associated with childhood obesity [28]. As both
fetal growth and childhood obesity is associated with asthma, further information regarding
the associations of peak weight and height velocity with respiratory disorders seems valuable.
The objective of the current study was to examine the associations of peak weight and height
velocity to age 36 months with development of recurrent LRTIs and asthma. A comparison be-
tween discordant sibling pairs adjusts for confounding by shared genetic and environmental
factors. Differences between a standard and a sibling pair analysis may therefore indicate con-
founding by factors that are shared by siblings [29]. The current study therefore also incorpo-
rated a sibling pair comparison when examining the association of early childhood growth
with respiratory disorders.
MATERIALS ANDMETHODS
Study subjects
The study population was the Norwegian Mother and Child Cohort Study (MoBa), which is a
population-based pregnancy cohort in Norway [30,31]. MoBa recruited pregnant women at
18 gestational weeks across Norway between 1999 and 2008. The participation rate was 40.6%.
Mothers could participate with multiple pregnancies, resulting in approximately 95,200
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mothers and 114,500 children. We used data available around March 2014, comprising
114,761 children. MoBa was linked to the Medical Birth Registry of Norway (MBRN). Children
not linked to the MBRN (n = 499) and multiple births (n = 3,971) were not eligible for the cur-
rent study. We used information from questionnaires at 18 and 30 gestational weeks, and when
the child was 6-, 18-, 36- months and 7 years. The study is reported according to the Strength-
ening the Reporting of Observational Studies in Epidemiology (STROBE) recommendations.
Ethics statement
The Norwegian Data Inspectorate and the Regional Ethics Committee for Medical Research
for South/East Norway approved this study. All participants in MoBa gave written informed
consent.
Exposure
Birth weight and height was gathered from the MBRN. Mothers reported anthropometric mea-
surements on their child’s health report cards as recorded by public health nurses according to
guidelines from the Norwegian Directorate of Health at 6 weeks and 3, 6, 8, 12, 15–18, 24 and
36 months [32]. The mother also reported the child’s weight and height at 7 years. Growth
curves for the child’s growth the first 36 months of life were fitted using the Reed1 model for
each gender separately: Y = A + Bt + Cln(t+30) + D/(t+30) [33–35]. The Reed1 model is de-
scribed in more detail in (S1 Text). The Reed1 model fits growth the first 36 months among
MoBa children best compared to other well-known growth models [36]. We decided a priori
that the exposures of interest were the peak weight and height velocity as calculated using the
first derivative of the Reed1 model. We used multilevel mixed-effects linear regression to im-
plement the Reed1 model among children with a minimum of three postnatal anthropometric
measurements.
Outcome
We defined current asthma at 36 months by maternal report of current asthma in combination
with having used an inhaled asthma medication in the past year. Inhaled asthma medications
were extracted from an open ended question which asked the mother to list the names of all
medications the child had taken and included glucocorticoids and/or beta-2 agonists. LRTIs in-
cluded maternal report of pneumonia, bronchitis, and/or respiratory syncytial virus when the
child was 6 and 18 months and maternal report of pneumonia and/or bronchitis at 36 months.
Mothers reported frequency of LRTIs by 6 months, between 6 and 18 months, and between 18
and 36 months. We classified recurrent LRTIs by 36 months as three or more LRTIs. Current
asthma at 7 years was defined by maternal report of asthma symptoms the past year in combi-
nation with having used an asthma medication the past year. The mother responded either yes
or no to a closed ended question regarding whether the child had used any medications for
asthma the past year when the child was 7 years.
Covariates
Potential confounders included characteristics that might influence the child’s growth and de-
velopment of respiratory disorders. We illustrated this through a directed acyclic graph (DAG;
S1 Fig.). Maternal characteristics included age, parity, education, salary, smoking during preg-
nancy and folate intake during pregnancy [37–39]. Characteristics indicating genetic predispo-
sition included maternal and paternal length, body mass index (BMI) and asthma. Child
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characteristics included gender, gestational age and whether the child was given breast milk as
the only source of milk the first 6 months. Covariates were categorized as indicated in Table 1.
Statistical Analysis
Evaluating fractional polynomial smoothed plots of peak weight and height velocity the first 36
months of life with risk of the respiratory disorders of interest, there was no strong indication
of any nonlinear associations. We examined the associations of one standard deviation (SD) in-
crease in peak weight and height velocity with child respiratory disorders by log-binomial re-
gression, reporting relative risks (RR) and 95% confidence intervals (CI). To account for
siblings, we used cluster variance estimations. Multivariable regression analysis was used to cal-
culate adjusted RR (adj.RR), adjusting for all potential confounders identified. To examine
whether the associations of peak weight and height velocities with child respiratory disorders
was mediated through the child’s BMI at the time of disease classification, we adjusted for this
covariate in a second multivariable model. We further evaluated potential effect modification
of preterm birth and intrauterine growth on the associations by including product terms in the
multivariable models. Preterm birth was classified as being born before 37 gestational weeks.
Intrauterine growth was classified as the birth weight being small (< 10th percentile), normal
(10th–90th percentile) and large (> 90th percentile) for gestational age. The amount of missing
information for individual covariates was generally low (< 2%). However, we conducted multi-
ple imputation using chained equations, imputing a total of 20 datasets. The results from the
multiple imputation analysis are provided in the tables in the paper while the results from the
complete case analysis are provided in S1 Table. To assess selection bias due to non-response
to follow-up questionnaires we used inverse probability weighting. The weights were the prob-
ability of having the necessary follow-up information among eligible children. As a secondary
analysis, we performed a paired analysis of siblings who were discordant for the respiratory dis-
orders using conditional logistic regression, reporting odds ratios (OR) and 95% CI. The statis-
tical significance level was 5% for all tests and comparisons. All analyses were conducted in
STATA version 13 (Statacorp, Texas).
RESULTS
Of the 110,291 eligible children, 50,311 children were included in the analysis of current asth-
ma at 36 months while 47,905 children were included in the analysis of recurrent LRTIs by 36
months (Fig. 1). Among the 50,311 children in the analysis of current asthma at 36 months, a
total of 39,211 children had reached age 7, out of which 24,827 had follow-up information
from the 7 year questionnaire and were included in the analysis of current asthma at 7 years
(Fig. 1). Characteristics were similar in the sample for current asthma at 36 months and 7 years
(Table 1). The mean peak weight velocity was 15.1 kg per year (SD 6.4 kg). The mean age at
peak weight velocity was 14 days, where 30.4% had peak weight velocity after birth. The mean
peak height velocity was 62.0 cm per year (SD 15.2). The mean age at peak height velocity was
8 days, where 15.4% had peak height velocity after birth. Among children who experienced
peak weight velocity after birth, there was a higher proportion of girls, children born preterm
and a higher proportion of children born small for gestational age. Similar characteristics were
seen for children who experienced their peak height velocity after birth. The correlation be-
tween peak weight and height velocity with gestational age, birth weight and height, in addition
to later anthropometric measurements are provided in S2 Table.
A total of 5.7% of children had current asthma at 36 months, 4.3% of children experienced
recurrent LRTIs by 36 months and 5.1% had current asthma at 7 years. Peak weight velocity
was positively associated with current asthma at 36 months, adj. RR 1.22 (95% CI: 1.18, 1.26)
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Table 1. Distribution of characteristics among individuals with follow-up information available for the analysis of asthma at 36 months and
current asthma at 7 years.
Characteristic Category Sample current asthma
at 36 months (N = 50,311)
Sample current asthma
at 7 years (N = 24,827)
Maternal age at delivery (Mean (SD)) NA 30.4 (4.4) 30.5 (4.3)
Maternal parity (%) Primiparous 48.2 45.8
1 33.9 34.9
2 14.1 15.1
3 or more 3.8 4.2
Maternal education (%) Less than high school 5.3 5.4
High school 26.6 27.7
Up to 4 years of college 43.3 44.9
More than 4 years of college 24.8 22.0
Maternal yearly salary(%) <200,000 NOK 25.8 27.9
200–400,000 NOK 61.8 62.6
>400,000 NOK 12.5 9.5
Maternal height in cm (Mean (SD)) NA 168.3 (5.9) 168.3 (5.9)
Maternal pre-pregnancy BMI (%) Underweight (<18.5) 2.9 2.7
Normal weight (18.5–24.9) 66.9 66.7
Overweight (25–29.9) 21.6 22.1
Obese (> = 30) 8.6 8.5
Paternal height in cm (Mean (SD)) NA 181.6 (6.4) 181.6 (6.4)
Paternal BMI (%) Underweight (<18.5) 0.2 0.2
Normal weight (18.5–24.9) 46.1 46.2
Overweight (25–29.9) 45.5 45.6
Obese (> = 30) 8.3 8.0
Maternal smoking during pregnancy (%) No 92.7 92.5
Yes 7.3 7.5
Maternal folate intake during pregnancy (%) None 12.7 14.2
Only ﬁrst trimester 24.1 21.8
Only after ﬁrst trimester 8.9 10.6
Both ﬁrst trimester and after 54.3 53.3
Maternal asthma (%) No 92.9 93.0
Yes 7.1 7.0
Paternal asthma (%) No 91.2 91.5
Yes 8.9 8.5
Child gender (%) Male 51.1 51.2
Female 48.9 48.8
Child gestational age in weeks (Mean (SD)) NA 39.5 (1.7) 39.5 (1.7)
Breastfeeding 0–6 months (%) a None 2.5 2.5
Partial 52.7 51.7
Exclusive 44.8 45.8
SD: standard deviation, BMI: body mass index
The amount of missing information on individual covariates was generally low (<2%).
a Breastfeeding the ﬁrst 6 months characterized as partial if the mother reported giving the child breast milk and another source of milk (i.e. formula).
Breastfeeding characterized as exclusive if the mother reported only giving the child breast milk throughout the ﬁrst 6 months of life and no other source of
milk (i.e. formula).
doi:10.1371/journal.pone.0116362.t001
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Figure 1. Illustration of sample size. LRTIs- lower respiratory tract infections. aSome versions of questionnaires did not ask about frequency/number of
LRTIs.
doi:10.1371/journal.pone.0116362.g001
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per SD increase, recurrent LRTIs by 36 months, adj. 1.14 (95% CI: 1.10, 1.19) per SD increase,
and current asthma at 7 years, adj. RR 1.13 (95% CI: 1.07, 1.19) per SD increase (Table 2).
These positive associations between peak weight velocity and respiratory disorders remained
after additional adjustment for the child’s BMI development. Peak height velocity was not asso-
ciated with any of the respiratory disorders.
The positive association of peak weight velocity with child respiratory disorders tended to
be stronger among the 95.5% of children born at term, but the test for multiplicative interaction
by preterm delivery was not statistically significant (>0.1). In the stratified analysis by intra-
uterine growth, there was a tendency for an inverse association between peak height velocity
and all the respiratory disorders of interest among the 10.2% of children born small for gesta-
tional age (adj. RR ~0.8). However, the tests for multiplicative interaction indicated that the as-
sociation of peak height velocity with the respiratory disorders was not significantly different
between children born small, normal and large for gestational age (all p-values>0.1). The anal-
ysis using inverse probability weighting to evaluate selection bias yielded similar results as the
un-weighted analysis (S3 Table).
There were 488 sibling pairs discordant for asthma at 36 months. In the sibling pair analysis,
peak weight velocity showed a positive association with asthma at 36 months, adj. OR 1.27
(95% CI: 1.04, 1.55) per SD increase (Table 3). There were 370 sibling pairs discordant for re-
current LRTIs. Peak weight velocity showed no significant association with recurrent LRTIs in
the sibling pair analysis, adj. OR 0.93 (95% CI: 0.75, 1.17), while peak height velocity showed
an inverse association, adj. RR 0.81 (0.66, 0.98) per SD increase (Table 3). There were 127 sib-
ling pairs discordant for current asthma at 7 years. Neither peak weight velocity nor peak
height velocity showed a significant association with current asthma at 7 years.
DISCUSSION
In this large population based study, peak weight velocity was positively associated with current
asthma at 36 months, recurrent LRTIs by 36 months and current asthma at 7 years. These posi-
tive associations were independent of the child’s BMI development. Peak height velocity
showed no clear association with any of the respiratory disorders evaluated. The sibling pair
Table 2. Associations of one standard deviation increase in peak weight and height velocity the ﬁrst 36 months of life with development of
respiratory disorders.
Outcome Sample size Exposure Crude RR (95% CI) Adj. RR (95% CI)a Adj. RR (95% CI)b
Current asthma at 36 months 50,311 Peak weight velocity 1.24 (1.20, 1.28) 1.22 (1.18, 1.26) 1.24 (1.19, 1.28)
Peak height velocity 0.97 (0.93, 1.01) 0.97 (0.93, 1.01) 0.97 (0.93, 1.01)
Recurrent LRTIs by 36 months 47,905 Peak weight velocity 1.17 (1.13, 1.22) 1.14 (1.10, 1.19) 1.14 (1.09, 1.19)
Peak height velocity 0.98 (0.93, 1.02) 0.96 (0.91, 1.01) 0.96 (0.91, 1.01)
Current asthma at 7 years 24,827 Peak weight velocity 1.14 (1.08, 1.20) 1.13 (1.07, 1.19) 1.13 (1.07, 1.20)
Peak height velocity 0.98 (0.93, 1.04) 1.01 (0.96, 1.08) 1.01 (0.95, 1.08)
LRTIs- lower respiratory tract infections
aAdjusted for maternal age, maternal parity, maternal education, maternal salary, maternal height, maternal pre-pregnancy BMI, paternal height, paternal
BMI, maternal folate intake during pregnancy, maternal smoking during pregnancy, maternal asthma, paternal asthma, child gender, gestational age and
breast feeding the ﬁrst 6 months of life.
bAdditional adjustment for the child’s BMI at 36 months (current asthma at 36 months and recurrent LRTIs by 36 months) or 7 years (current asthma at 7
years).
Multiple imputation of missing covariate information conducted using chained equations. A total of 20 imputed datasets generated for pooled analysis.
doi:10.1371/journal.pone.0116362.t002
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analysis supported the positive association of peak weight velocity with current asthma at
36 months.
Most previous studies of infant growth and asthma evaluated change in standard deviation
scores or absolute change in weight between two measurement points [11,15–18]. One study
evaluated conditional weight gain during infancy [14]. Our findings support previous studies
indicating that weight increase the first 3 to 6 months is positively associated with asthma
while length increase during this age period shows no association [11,14]. The recent meta-
analysis further showed a positive association of absolute weight gain between birth and
12 months of age with asthma development [19].
Only two previous studies used a longitudinal data analysis to model the child’s growth.
One study used a multilevel model with restricted cubic splines, reporting a positive association
of weight increase the first 12 months with asthma [12]. A German study previously examined
peak weight and height velocity using the Reed1 model and development of asthma [13]. In ac-
cordance with our study, they reported a positive association between peak weight velocity and
asthma development during the first 10 years of age, adjusted hazard ratio 1.22 (95% CI: 1.02–
1.47) per interquartile increase, and no association between peak height velocity and asthma
development, adjusted hazard ratio 1.08 (95% CI: 0.88, 1.31) per interquartile increase. In our
study, we found a similar association between peak weight velocity and recurrent LRTIs by
36 months.
Early infant growth might plausibly have a direct effect on lung development. Human lung
development has five overlapping stages that begins at approximately 3 weeks’ post-conception
and extends into the second year of life [22]. Alveologenesis starts around 29 gestational weeks
and continues after birth. This is therefore the stage of lung development during which the
peak weight and height velocity was evaluated. Lung development is influenced by genes,
transcription factors, growth factors and cytokines [22].
Table 3. Sibling pair analysis of the associations of one standard deviation increase in peak weight and height velocity the ﬁrst 36 months of
life with development of respiratory disorders.
Outcome Number of discordant sibling pairs in
analysis
Exposure Crude OR (95%
CI)
Adj OR (95%
CI)a
Adj OR (95%
CI)b
Current asthma at 36
months
488 Peak weight
velocity
1.36 (1.15, 1.60) 1.27 (1.04,
1.55)
1.26 (1.03,
1.55)
Peak height
velocity
1.14 (0.99, 1.32) 0.96 (0.80,
1.15)
0.96 (0.80,
1.15)
Recurrent LRTIs by 36
months
370 Peak weight
velocity
1.06 (0.88, 1.27) 0.93 (0.75,
1.17)
0.94 (0.75,
1.19)
Peak height
velocity
0.92 (0.78, 1.08) 0.81 (0.66,
0.98)
0.81 (0.66,
0.98)
Current asthma at 7 years 127 Peak weight
velocity
1.24 (0.92, 1.68) 1.03 (0.68,
1.55)
1.01 (0.66,
1.54)
Peak height
velocity
1.26 (0.97, 1.62) 1.19 (0.82,
1.72)
1.21 (0.83,
1.76)
LRTIs- lower respiratory tract infections
aAdjusted for maternal age, maternal parity, maternal education, maternal salary, maternal height, maternal pre-pregnancy BMI, paternal height, paternal
BMI, maternal folate intake during pregnancy, maternal smoking during pregnancy, maternal asthma, paternal asthma, child gender, gestational age and
breast feeding the ﬁrst 6 months of life.
bAdditional adjustment for the child’s BMI at 36 months (current asthma at 36 months and recurrent LRTIs by 36 months) or 7 years (current asthma at 7
years).
Multiple imputation of missing covariate information conducted using chained equations. A total of 20 imputed datasets generated for pooled analysis.
doi:10.1371/journal.pone.0116362.t003
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Intrauterine growth restriction often results in impaired lung development, poorer infant
lung function and postnatal catch-up growth [40,41]. Smaller weight gain between the second
and third trimester has been positively associated with peak weight velocity as calculated using
the Reed model [28]. In addition, gradual length gain between second and third trimester was
positively associated with peak height velocity [28]. We only saw an association of peak weight
velocity with respiratory disorders while we saw no association with peak height velocity. The
positive association between peak weight velocity and childhood respiratory disorders might
partly reflect intrauterine growth. However, we found no difference in the association between
peak weight velocity and respiratory disorders among children born small, normal and large
for gestational age.
Another possible explanation for the association between peak weight velocity and child-
hood respiratory disorders includes genetic and/or epigenetic mechanisms. One of the most
replicated loci in genome wide association studies of childhood asthma development is the
17q12-21 loci [42]. The effect of the 17q12-21 loci is enhanced by fetal and infant smoke expo-
sure [43]. In the MoBa cohort, both prenatal smoke exposure and birth weight is associated
with the child’s cord blood DNAmethylation pattern [24,44]. Prenatal smoke exposure is a
common risk factor for low birth weight, which influences postnatal growth, in addition to
asthma development. Therefore, common genetic and/or epigenetic mechanisms might under-
lie the association between peak weight velocity and childhood respiratory disorders.
There might also be common environmental factors influencing prenatal/postnatal growth
and childhood respiratory disorders. Infant feeding is such an example [26,27]. Environmental
toxins might also constitute common predictors for postnatal growth and childhood respirato-
ry disorders. Maternal PCB level during pregnancy has been associated with both birth weight
and asthma development [45,46]. A variety of environmental factors might therefore influence
early postnatal growth and development of childhood respiratory disorders underlying the ob-
served positive association.
MoBa provided a unique opportunity to examine the research question of interest due to its
size, availability of 10 anthropometric measurement points, ability to adjust for a large number
of potential confounding factors, and the siblings participating in the cohort. Results from sev-
eral previous studies, the current study, and the meta-analysis largely point in the same direc-
tion. We supplement the existing literature by showing that the previously observed
associations are most likely not due to factors that previous studies could not adjust for, includ-
ing paternal asthma and anthropometric values. Furthermore, we found that peak weight ve-
locity by 36 months was also positively associated with recurrent LRTIs. Interestingly, peak
weight velocity showed a strong correlation with absolute weight increase from birth to 12
month (correlation coefficient 0.76). Our findings and those from the recent meta-analysis
might therefore reflect the same phenomenon. This is the first study to use a sibling pair analy-
sis when examining the association of growth and respiratory disorders. The sibling pair analy-
sis yielded similar associations of peak weight and height velocity with asthma at 36 months.
This was not the case for the other two respiratory outcomes. However, we remain cautious in
our interpretation of the sibling pair analysis for asthma at 7 years due to the few number of
discordant sibling pairs.
The current study has limitations. Maternal report of anthropometric measurements may
have caused misclassification. By asking the mother to refer to the child’s health report card,
we attempted to minimize this. Furthermore, the Reed1 growth model smoothes the growth
curves over the entire growth period and might therefore miss extreme growth changes over
very short time periods. Asthma among preschool age children is often characterized by tran-
sient wheezing due to respiratory tract infections. In MoBa, 40% of children had experienced
wheezing symptoms the previous year when they were 18 months of age. This is substantially
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lower than the prevalence of asthma at 36 months and might indicate that Norwegian mothers
are not reporting all early wheezing symptoms as asthma. Notably, adjusting the association of
peak weight and height velocity with asthma development for LRTIs, ear infections and throat
infections did not change the results. The asthma classification used in the current study might
also be considered fairly stringent compared to the classification used by the global imitative
for asthma of wheezing symptoms the past 12 months. A similar asthma case definition as the
one used in the current study was validated among 5 year old children in a Finish study popula-
tion against registered use of asthma medications indicating a high validity [47]. Maternal re-
port of the child’s use of asthma medications the last year in the 7 year questionnaire in MoBa
also showed a high validity against registered use of asthma medications in the Norwegian Pre-
scription Database [48]. Excluding the use of asthma medications from the definitions yielded
a prevalence of current asthma at 36 months of 6.4% and a prevalence of current asthma at 7
years of 5.2%. Notably, these less stringent asthma definitions yielded the same associations
with peak weight and height velocity. Differential misclassification of respiratory disorders is
unlikely due to the prospective data collection. Any misclassification would therefore bias the
results towards the null. A selection bias might have occurred due to the initial participation
rate into MoBa. Comparing MoBa participants to all pregnant women who gave birth during
the MoBa inclusion period as registered in the MBRN indicated that MoBa participants were
older, less likely to be single, less likely to have more than two previous deliveries and less likely
to smoke during pregnancy [31]. However, these differences were not found to influence expo-
sure outcome associations. Overall, we do not think that the initial participation rate is a strong
source of selection bias in the current study. However, we cannot exclude the possibility that
the differences identified between MoBa participants and all pregnant women registered in the
MBRNmight reduce the generalizability of the study results with regard to certain underrepre-
sented high-risk groups. The current study further required that the mothers had responded to
several follow-up questionnaires. However, the results of the analysis using inverse probability
weighting to make the study population more comparable to all eligible MoBa participants
yielded similar results. We therefore do not think that the observed associations are strongly
influenced by selection bias.
In conclusion, higher peak weight velocity, achieved during the immediate postnatal period,
increased the risk of respiratory disorders. This might be explained by an influence on neonatal
lung development, shared genetic/epigenetic mechanisms and/or environmental factors.
Supporting Information
S1 Table. Association per standard deviation increase in peak weight and height velocity
the first 36 months of life with childhood respiratory disorders: results from complete case
analysis.
(DOCX)
S2 Table. Spearman rank correlation coefficients between peak weight and height velocity
the first 36 months of life with gestational age and all anthropometric measurements.
(DOCX)
S3 Table. Association per standard deviation increase in peak weight and height velocity
the first 36 months of life with childhood respiratory disorders: results using inverse proba-
bility weighting.
(DOCX)
S1 Text. Description of growth curve modelling.
(DOCX)
Postnatal Growth and Asthma
PLOSONE | DOI:10.1371/journal.pone.0116362 January 30, 2015 10 / 13
S1 Fig. Directed acyclic graph. Child characteristics: child gender and breastfeeding the first
6 months. Maternal characteristics: maternal age, maternal education, maternal salary, mater-
nal parity, maternal smoking during pregnancy and maternal folate intake during pregnancy.
Genes: Genetic predisposition for growth and asthma. Measured by maternal height, maternal
body mass index, paternal height and paternal body mass index, in addition to maternal and
paternal history of asthma.
(TIF)
Acknowledgments
The authors appreciate the input of Dr. Pål Súren regarding the analytical approach in the
early phases of the study. We are grateful to all families participating in the Norwegian Mother
and Child Cohort Study.
Author Contributions
Conceived and designed the experiments: WN PN SEH SJL MCM. Performed the experiments:
MCMHS. Analyzed the data: MCMHS. Wrote the paper: MCMWN PN SEH SJL.
References
1. Braman SS (2006) The global burden of asthma. Chest 130: 4s–12s. doi: 10.1378/chest.130.1_suppl.
4S PMID: 16840363
2. Henderson J, Granell R, Sterne J (2009) The search for new asthma phenotypes. Arch Dis Child 94:
333–336. doi: 10.1136/adc.2008.143636 PMID: 19147620
3. Tedner SG, Ortqvist AK, Almqvist C (2012) Fetal growth and risk of childhood asthma and allergic dis-
ease. Clin Exp Allergy 42: 1430–1447. doi: 10.1111/j.1365-2222.2012.03997.x PMID: 22994341
4. Turner S, Prabhu N, Danielan P, McNeill G, Craig L, et al. (2011) First- and second-trimester fetal size
and asthma outcomes at age 10 years. Am J Respir Crit Care Med 184: 407–413. doi: 10.1164/rccm.
201012-2075OC PMID: 21642247
5. Metsala J, Kilkkinen A, Kaila M, Tapanainen H, Klaukka T, et al. (2008) Perinatal factors and the risk of
asthma in childhood—a population-based register study in Finland. Am J Epidemiol 168: 170–178.
doi: 10.1093/aje/kwn105 PMID: 18511427
6. Sevelsted A, Bisgaard H (2012) Neonatal size in term children is associated with asthma at age 7, but
not with atopic dermatitis or allergic sensitization. Allergy 67: 670–675. doi: 10.1111/j.1398-9995.2012.
02805.x PMID: 22381045
7. Mannino DM, Mott J, Ferdinands JM, Camargo CA, FriedmanM, et al. (2006) Boys with high body mas-
ses have an increased risk of developing asthma: findings from the National Longitudinal Survey of
Youth (NLSY). Int J Obes (Lond) 30: 6–13. doi: 10.1038/sj.ijo.0803145 PMID: 16344843
8. Scholtens S, Wijga AH, Seidell JC, Brunekreef B, de Jongste JC, et al. (2009) Overweight and changes
in weight status during childhood in relation to asthma symptoms at 8 years of age. J Allergy Clin Immu-
nol 123: 1312–1318. doi: 10.1016/j.jaci.2009.02.029 PMID: 19409606
9. Taveras EM, Rifas-Shiman SL, Camargo CA Jr, Gold DR, Litonjua AA, et al. (2008) Higher adiposity in
infancy associated with recurrent wheeze in a prospective cohort of children. J Allergy Clin Immunol
121: 1161–1166. doi: 10.1016/j.jaci.2008.03.021 PMID: 18466784
10. Rzehak P, Wijga AH, Keil T, Eller E, Bindslev-Jensen C, et al. (2013) Body mass index trajectory clas-
ses and incident asthma in childhood: results from 8 European Birth Cohorts—a Global Allergy and
Asthma European Network initiative. J Allergy Clin Immunol 131: 1528–1536. doi: 10.1016/j.jaci.2013.
01.001 PMID: 23403049
11. Sonnenschein-van der Voort AM, Jaddoe VW, Raat H, Moll HA, Hofman A, et al. (2012) Fetal and infant
growth and asthma symptoms in preschool children: the Generation R Study. Am J Respir Crit Care
Med 185: 731–737. doi: 10.1164/rccm.201107-1266OC PMID: 22268138
12. Anderson EL, Fraser A, Martin RM, Kramer MS, Oken E, et al. (2013) Associations of postnatal growth
with asthma and atopy: the PROBIT Study. Pediatr Allergy Immunol 24: 122–130. doi: 10.1111/pai.
12049 PMID: 23374010
Postnatal Growth and Asthma
PLOSONE | DOI:10.1371/journal.pone.0116362 January 30, 2015 11 / 13
13. Flexeder C, Thiering E, Bruske I, Koletzko S, Bauer CP, et al. (2012) Growth velocity during infancy
and onset of asthma in school-aged children. Allergy 67: 257–264. doi: 10.1111/j.1398-9995.2011.
02748.x PMID: 22092112
14. Pike KC, Crozier SR, Lucas JS, Inskip HM, Robinson S, et al. (2010) Patterns of fetal and infant growth
are related to atopy and wheezing disorders at age 3 years. Thorax 65: 1099–1106. doi: 10.1136/thx.
2010.134742 PMID: 20956394
15. Rona RJ, Smeeton NC, Bustos P, Amigo H, Diaz PV (2005) The early origins hypothesis with an em-
phasis on growth rate in the first year of life and asthma: a prospective study in Chile. Thorax 60: 549–
554. doi: 10.1136/thx.2004.032359 PMID: 15994261
16. van der Gugten AC, KoopmanM, Evelein AM, Verheij TJ, Uiterwaal CS, et al. (2012) Rapid early weight
gain is associated with wheeze and reduced lung function in childhood. Eur Respir J 39: 403–410. doi:
10.1183/09031936.00188310 PMID: 21852338
17. Mai XM, Gaddlin PO, Nilsson L, Leijon I (2005) Early rapid weight gain and current overweight in rela-
tion to asthma in adolescents born with very low birth weight. Pediatr Allergy Immunol 16: 380–385.
doi: 10.1111/j.1399-3038.2005.00290.x PMID: 16101929
18. Paul IM, Camera L, Zeiger RS, Guilbert TW, Bacharier LB, et al. (2010) Relationship between infant
weight gain and later asthma. Pediatr Allergy Immunol 21: 82–89. doi: 10.1111/j.1399-3038.2009.
00926.x PMID: 19725894
19. Sonnenschein-van der Voort AM, Arends LR, de Jongste JC, Annesi-Maesano I, Arshad SH, et al.
(2014) Preterm birth, infant weight gain, and childhood asthma risk: A meta-analysis of 147,000 Euro-
pean children. J Allergy Clin Immunol 133: 1317–1329. doi: 10.1016/j.jaci.2013.12.1082 PMID:
24529685
20. Bisgaard H, Loland L, Holst KK, Pipper CB (2009) Prenatal determinants of neonatal lung function in
high-risk newborns. J Allergy Clin Immunol 123: 651–657. doi: 10.1016/j.jaci.2008.11.036 PMID:
19152964
21. Bisgaard H, Jensen SM, Bonnelykke K (2012) Interaction between asthma and lung function growth in
early life. Am J Respir Crit Care Med 185: 1183–1189. doi: 10.1164/rccm.201110-1922OC PMID:
22461370
22. Galambos C, Demello DE (2008) Regulation of alveologenesis: clinical implications of impaired growth.
Pathology 40: 124–140. doi: 10.1080/00313020701818981 PMID: 18203035
23. Morrisey EE, Hogan BL (2010) Preparing for the first breath: genetic and cellular mechanisms in lung
development. Dev Cell 18: 8–23. doi: 10.1016/j.devcel.2009.12.010 PMID: 20152174
24. Engel SM, Joubert BR, Wu MC, Olshan AF, Haberg SE, et al. (2014) Neonatal genome-wide methyla-
tion patterns in relation to birth weight in the Norwegian Mother and Child Cohort. Am J Epidemiol 179:
834–842. doi: 10.1093/aje/kwt433 PMID: 24561991
25. Sharma S, Tantisira K, Carey V, Murphy AJ, Lasky-Su J, et al. (2010) A role for Wnt signaling genes in
the pathogenesis of impaired lung function in asthma. Am J Respir Crit Care Med 181: 328–336. doi:
10.1164/rccm.200907-1009OC PMID: 19926868
26. Brew BK, Allen CW, Toelle BG, Marks GB (2011) Systematic review and meta-analysis investigating
breast feeding and childhood wheezing illness. Paediatr Perinat Epidemiol 25: 507–518. doi: 10.1111/
j.1365-3016.2011.01233.x PMID: 21980940
27. Haschke F, Steenhout P, Grathwohl D, Haschke-Becher E (2013) Evaluation of growth and early infant
feeding: a challenge for scientists, industry and regulatory bodies. World Rev Nutr Diet 106: 33–38.
doi: 10.1159/000342559 PMID: 23428678
28. Mook-Kanamori DO, Durmus B, Sovio U, Hofman A, Raat H, et al. (2011) Fetal and infant growth and
the risk of obesity during early childhood: the Generation R Study. Eur J Endocrinol 165: 623–630. doi:
10.1530/EJE-11-0067 PMID: 21775498
29. Frisell T, Oberg S, Kuja-Halkola R, Sjolander A (2012) Sibling comparison designs: bias from non-
shared confounders and measurement error. Epidemiology 23: 713–720. doi: 10.1097/EDE.
0b013e31825fa230 PMID: 22781362
30. Magnus P, Irgens LM, Haug K, Nystad W, Skjaerven R, et al. (2006) Cohort profile: the Norwegian
Mother and Child Cohort Study (MoBa). Int J Epidemiol 35: 1146–1150. doi: 10.1093/ije/dyl170 PMID:
16926217
31. Nilsen RM, Vollset SE, Gjessing HK, Skjaerven R, Melve KK, et al. (2009) Self-selection and bias in a
large prospective pregnancy cohort in Norway. Paediatr Perinat Epidemiol 23: 597–608. doi: 10.1111/
j.1365-3016.2009.01062.x PMID: 19840297
32. Norwegian Directorate of Health (2010) Nasjonale faglige retningslinjer for veiing og måling i
helsestasjons- og skolehelsetjenesten (In English: National guidelines for weighing and measurements
in well-baby clinics and school health services). Available: http://www.helsedirektoratet.no/
Postnatal Growth and Asthma
PLOSONE | DOI:10.1371/journal.pone.0116362 January 30, 2015 12 / 13
publikasjoner/nasjonale-faglige-retningslinjer-for-veiing-og-maling/Sider/default.aspx. 07.12.11.
Accessed 2013 January 1.
33. Berkey CS, Reed RB (1987) A model for describing normal and abnormal growth in early childhood.
Hum Biol 59: 973–987. PMID: 3443447
34. Chirwa ED, Griffiths PL, Maleta K, Norris SA, Cameron N (2014) Multi-level modelling of longitudinal
child growth data from the Birth-to-Twenty Cohort: a comparison of growth models. Ann Hum Biol 41:
166–177. doi: 10.3109/03014460.2013.839742 PMID: 24111514
35. Simondon KB, Delpeuch F, Cornu A (1992) Comparative Study of Five Growth Models Applied to
Weight Data From Congolese Infants Between Birth and 13 Months of Age. Am J Hum Biol 4: 327–
335.
36. Suren P, Stoltenberg C, BresnahanM, Hirtz D, Lie KK, et al. (2013) Early growth patterns in children
with autism. Epidemiology 24: 660–670. doi: 10.1097/EDE.0b013e31829e1d45 PMID: 23867813
37. Weber D, Stuetz W, BernhardW, Franz A, Raith M, et al. (2013) 5-Methyltetrahydrofolate and thiamine
diphosphate in cord-blood erythrocytes of preterm versus term newborns. Eur J Clin Nutr 67: 1029–
1035. doi: 10.1038/ejcn.2013.158 PMID: 24002042
38. Haberg SE, London SJ, Nafstad P, Nilsen RM, Ueland PM, et al. (2011) Maternal folate levels in preg-
nancy and asthma in children at age 3 years. J Allergy Clin Immunol 127: 262–264. doi: 10.1016/j.jaci.
2010.10.004 PMID: 21094522
39. Haberg SE, London SJ, Stigum H, Nafstad P, NystadW (2009) Folic acid supplements in pregnancy
and early childhood respiratory health. Arch Dis Child 94: 180–184. doi: 10.1136/adc.2008.142448
PMID: 19052032
40. Gluckman PD, Hanson MA, Cooper C, Thornburg KL (2008) Effect of in utero and early-life conditions
on adult health and disease. N Engl J Med 359: 61–73. doi: 10.1056/NEJMra0708473 PMID:
18596274
41. Maritz GS, Cock ML, Louey S, Joyce BJ, Albuquerque CA, et al. (2001) Effects of fetal growth restric-
tion on lung development before and after birth: a morphometric analysis. Pediatr Pulmonol 32: 201–
210. doi: 10.1002/ppul.1109 PMID: 11536449
42. Dijk FN, de Jongste JC, Postma DS, Koppelman GH (2013) Genetics of onset of asthma. Curr Opin
Allergy Clin Immunol 13: 193–202. doi: 10.1097/ACI.0b013e32835eb707 PMID: 23407123
43. van der Valk RJ, Duijts L, Kerkhof M, Willemsen SP, Hofman A, et al. (2012) Interaction of a 17q12 vari-
ant with both fetal and infant smoke exposure in the development of childhood asthma-like symptoms.
Allergy 67: 767–774. doi: 10.1111/j.1398-9995.2012.02819.x PMID: 22469062
44. Joubert BR, Haberg SE, Nilsen RM, Wang X, Vollset SE, et al. (2012) 450K epigenome-wide scan
identifies differential DNAmethylation in newborns related to maternal smoking during pregnancy.
Environ Health Perspect 120: 1425–1431. doi: 10.1289/ehp.1205412 PMID: 22851337
45. Govarts E, Nieuwenhuijsen M, Schoeters G, Ballester F, Bloemen K, et al. (2012) Birth weight and pre-
natal exposure to polychlorinated biphenyls (PCBs) and dichlorodiphenyldichloroethylene (DDE): a
meta-analysis within 12 European Birth Cohorts. Environ Health Perspect 120: 162–170. doi: 10.1289/
ehp.1103767 PMID: 21997443
46. Hansen S, StromM, Olsen SF, Maslova E, Rantakokko P, et al. (2014) Maternal concentrations of per-
sistent organochlorine pollutants and the risk of asthma in offspring: results from a prospective cohort
with 20 years of follow-up. Environ Health Perspect 122: 93–99. doi: 10.1289/ehp.1206397 PMID:
24162035
47. Nwaru BI, Lumia M, Kaila M, Luukkainen P, Tapanainen H, et al. (2011) Validation of the Finnish
ISAAC questionnaire on asthma against anti-asthmatic medication reimbursement database in 5-year-
old children. Clin Respir J 5: 211–218. doi: 10.1111/j.1752-699X.2010.00222.x PMID: 21801323
48. Furu K, Karlstad O, Skurtveit S, Haberg SE, Nafstad P, et al. (2011) High validity of mother-reported
use of antiasthmatics among children: a comparison with a population-based prescription database.
J Clin Epidemiol 64: 878–884. doi: 10.1016/j.jclinepi.2010.10.014 PMID: 21232920
Postnatal Growth and Asthma
PLOSONE | DOI:10.1371/journal.pone.0116362 January 30, 2015 13 / 13
